Parma consensus statement on metabolic disruptors

被引:0
作者
Jerrold J. Heindel
Frederick S. vom Saal
Bruce Blumberg
Patrizia Bovolin
Gemma Calamandrei
Graziano Ceresini
Barbara A. Cohn
Elena Fabbri
Laura Gioiosa
Christopher Kassotis
Juliette Legler
Michele La Merrill
Laura Rizzir
Ronit Machtinger
Alberto Mantovani
Michelle A. Mendez
Luisa Montanini
Laura Molteni
Susan C. Nagel
Stefano Parmigiani
Giancarlo Panzica
Silvia Paterlini
Valentina Pomatto
Jérôme Ruzzin
Giorgio Sartor
Thaddeus T. Schug
Maria E. Street
Alexander Suvorov
Riccardo Volpi
R. Thomas Zoeller
Paola Palanza
机构
[1] National Institute of Environmental Health Sciences,Division of Extramural Research and Training
[2] University of Missouri,Division of Biological Sciences
[3] University of California,Department of Developmental and Cell Biology
[4] University of Turin,Department of Life Sciences and Systems Biology
[5] Insituto Superiore di Sanita,Department of Cell Biology and Neurosciences
[6] University of Parma,Department of Clinical and Experimental Medicine
[7] Public Health Institute,Interdepartment Center for Environmental Science Research
[8] University of Bologna,Department of Neuroscience
[9] University of Parma,Department of Toxicology and Environmental Health
[10] VU University Amsterdam,Department of Health Sciences
[11] Department of Environmental Toxicology,School of Public Health
[12] University of California,Department of Pediatrics
[13] University of Milano-Bicocca,Department of Obstetrics, Gynecology and Women’s Health
[14] Sheba Medical Center and Tel-Aviv University,Faculty of Medicine
[15] Instituto Superiore di Sanita,Department of Neuroscience and Neuroscience Institute Cavalieri Ottolenghi (NICO)
[16] University of North Carolina at Chapel Hill,Department of Biology
[17] University of Parma,Department of Pharmacy and Biotechnology
[18] University of Milano-Bicocca,Department of Pediatrics
[19] University of Missouri,Department of Internal Medicine
[20] University of Parma,Department of Biology
[21] University of Turin,undefined
[22] University of Bergen,undefined
[23] University of Bologna,undefined
[24] University Hospital,undefined
[25] University of Parma,undefined
[26] University of Massachusetts,undefined
来源
Environmental Health | / 14卷
关键词
Metabolic disruptor; Obesogen; Obesity; Diabetes; Metabolic syndrome; Developmental Programming;
D O I
暂无
中图分类号
学科分类号
摘要
A multidisciplinary group of experts gathered in Parma Italy for a workshop hosted by the University of Parma, May 16–18, 2014 to address concerns about the potential relationship between environmental metabolic disrupting chemicals, obesity and related metabolic disorders. The objectives of the workshop were to: 1. Review findings related to the role of environmental chemicals, referred to as “metabolic disruptors”, in obesity and metabolic syndrome with special attention to recent discoveries from animal model and epidemiology studies; 2. Identify conclusions that could be drawn with confidence from existing animal and human data; 3. Develop predictions based on current data; and 4. Identify critical knowledge gaps and areas of uncertainty. The consensus statements are intended to aid in expanding understanding of the role of metabolic disruptors in the obesity and metabolic disease epidemics, to move the field forward by assessing the current state of the science and to identify research needs on the role of environmental chemical exposures in these diseases. We propose broadening the definition of obesogens to that of metabolic disruptors, to encompass chemicals that play a role in altered susceptibility to obesity, diabetes and related metabolic disorders including metabolic syndrome.
引用
收藏
相关论文
共 200 条
[1]  
O’Neill S(2015)Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies Obes Rev 16 1-12
[2]  
O’Driscoll L(2009)Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity Mol Cell Endocrinol 304 90-6
[3]  
Heindel JJ(2014)Prevalence of obesity in the United States JAMA 312 189-90
[4]  
vom Saal FS(1999)Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study Arch Intern Med 159 1450-6
[5]  
Ogden CL(2014)Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009 JAMA 311 1778-86
[6]  
Carroll MD(2012)Abdominal obesity and cardiovascular disease: is inflammation the missing link? Canadian J Cardiol 28 642-52
[7]  
Flegal KM(2008)Epidemiological and nutrition transition in developing countries: impact on human health and development Proc Nutrit Socy 67 82-90
[8]  
Burke JP(2011)Canaries in the coal mine: a cross-species analysis of plurality of obesity epidemics Proc Biol Sci 278 1626-32
[9]  
Williams K(2011)Developmental origins of health and disease: Moving from biological concepts to interventions and policy Int J Gynecol Obstetrics 115, Supplement 1 S3-5
[10]  
Gaskill SP(2014)Early life adversity and the epigenetic programming of hypothalamic-pituitary-adrenal function Dialogues Clin Neurosci 16 321-33